Insider Trading & Ownership - DAWES KAREN A

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for DAWES KAREN A
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-02-27
Sale
2024-02-28
9:56 pm
REPLIGEN CORPRGENDAWES KAREN A
Director
1,000$193.35$193,35087,367
(Direct)
View
2023-08-29
Sale
2023-08-30
4:06 pm
REPLIGEN CORPRGENDAWES KAREN A
Director
850$171.38$145,67383,741
(Direct)
View
2022-09-09
Sale
2022-09-09
4:14 pm
REPLIGEN CORPRGENDAWES KAREN A
Director
775$227.17$176,05776,401
(Direct)
View
2022-05-25
Sale
2022-05-26
5:17 pm
REPLIGEN CORPRGENDAWES KAREN A
Director
14,715$150.51$2,214,81976,532
(Direct)
View
2021-11-10
Sale
2021-11-12
5:12 pm
REPLIGEN CORPRGENDAWES KAREN A
Director
4,783$263.93$1,262,35591,247
(Direct)
View
2021-11-02
Sale
2021-11-04
5:41 pm
REPLIGEN CORPRGENDAWES KAREN A
Director
2,400$303.94$729,46791,247
(Direct)
View
2021-09-14
Sale
2021-09-15
5:46 pm
REPLIGEN CORPRGENDAWES KAREN A
Director
274$294.26$80,62893,647
(Direct)
View
2021-09-01
Sale
2021-09-02
4:29 pm
REPLIGEN CORPRGENDAWES KAREN A
Director
3,459$283.91$982,05893,921
(Direct)
View
2021-08-17
Sale
2021-08-19
4:42 pm
REPLIGEN CORPRGENDAWES KAREN A
Director
18,956$254.18$4,818,21993,921
(Direct)
View
2021-07-20
Sale
2021-07-22
8:25 pm
REPLIGEN CORPRGENDAWES KAREN A
Director
4,585$202.09$926,605112,877
(Direct)
View
2021-07-13
Sale(A)
2021-07-22
6:53 pm
REPLIGEN CORPRGENDAWES KAREN A
Director
1,520$202.23$307,395117,462
(Direct)
View
2021-07-13
Sale
2021-07-15
5:17 pm
REPLIGEN CORPRGENDAWES KAREN A
Director
1,520$202.23$307,390117,462
(Direct)
View
2021-05-11
Sale
2021-05-13
5:01 pm
REPLIGEN CORPRGENDAWES KAREN A
Director
285$176.85$50,402115,449
(Direct)
View
2021-05-04
Purchase
2021-05-06
4:29 pm
Vaccitech plcVACCDAWES KAREN A
Director
1,700$17$28,9001,700
(Direct)
View
2020-06-18
Sale
2020-06-22
4:42 pm
REPLIGEN CORPRGENDAWES KAREN A
Director
18,705$115.2$2,154,851100,734
(Direct)
View
2020-05-20
Sale
2020-05-21
9:08 pm
REPLIGEN CORPRGENDAWES KAREN A
Director
517$139.44$72,093119,439
(Direct)
View
2020-05-18
Sale(A)
2020-05-21
9:06 pm
REPLIGEN CORPRGENDAWES KAREN A
Director
1,600$137.78$220,448121,717
(Direct)
View
2020-04-20
Sale(A)
2020-05-21
9:03 pm
REPLIGEN CORPRGENDAWES KAREN A
Director
12,200$104.57$1,275,717132,634
(Direct)
View
2020-05-18
Sale
2020-05-19
8:46 pm
REPLIGEN CORPRGENDAWES KAREN A
Director
1,600$137.78$220,448121,717
(Direct)
View
2020-05-08
Sale
2020-05-11
8:23 pm
Assertio Therapeutics IncASRTDAWES KAREN A
Director
15,834$0.7914$12,53184,589
(Direct)
View
2020-04-20
Sale
2020-04-22
6:07 pm
REPLIGEN CORPRGENDAWES KAREN A
Director
12,200$104.57$1,275,717132,634
(Direct)
View
2020-02-21
Sale
2020-02-24
5:51 pm
REPLIGEN CORPRGENDAWES KAREN A
Director
4,000$98.7$394,793113,034
(Direct)
View
2019-06-17
Sale
2019-06-19
7:00 pm
REPLIGEN CORPRGENDAWES KAREN A
Director
1,295$77.35$100,168117,034
(Direct)
View
2019-06-13
Sale
2019-06-14
5:20 pm
Assertio Therapeutics IncASRTDAWES KAREN A
Director
12,500$3.1835$39,794100,423
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-27
Exercise
2024-02-28
9:56 pm
N/A
N/A
REPLIGEN CORPRGENDAWES KAREN A
Director
4,626$42.0787,367
(Direct)
View
2024-02-27
Exercise
2024-02-28
9:56 pm
N/A
2028-05-16
REPLIGEN CORPRGENDAWES KAREN A
Director
4,626$087,367
(Direct)
View
2023-08-29
Exercise
2023-08-30
4:06 pm
N/A
2024-05-15
REPLIGEN CORPRGENDAWES KAREN A
Director
7,392$083,741
(Direct)
View
2023-08-29
Exercise
2023-08-30
4:06 pm
N/A
N/A
REPLIGEN CORPRGENDAWES KAREN A
Director
7,392$18.1283,741
(Direct)
View
2023-05-18
Option Award
2023-05-22
9:26 pm
2024-05-18
2033-05-18
REPLIGEN CORPRGENDAWES KAREN A
Director
2,528$078,929
(Direct)
View
2023-05-11
Option Award
2023-05-12
4:05 pm
N/A
2033-05-11
Vaccitech plcVACCDAWES KAREN A
Director
19,197$019,197
(Direct)
View
2022-06-15
Ownership
2023-02-10
4:34 pm
N/A
2032-06-15
Vaccitech plcVACCDAWES KAREN A
Director
18,604$018,604
(Direct)
View
2022-05-26
Option Award
2022-05-31
8:21 pm
2023-05-26
2032-05-26
REPLIGEN CORPRGENDAWES KAREN A
Director
2,209$078,741
(Direct)
View
2021-11-10
Exercise
2021-11-12
5:12 pm
N/A
N/A
REPLIGEN CORPRGENDAWES KAREN A
Director
4,783$26.1291,247
(Direct)
View
2021-11-10
Exercise
2021-11-12
5:12 pm
N/A
2026-05-11
REPLIGEN CORPRGENDAWES KAREN A
Director
4,783$091,247
(Direct)
View
2021-09-01
Exercise
2021-09-02
4:29 pm
N/A
2027-05-18
REPLIGEN CORPRGENDAWES KAREN A
Director
3,459$093,921
(Direct)
View
2021-09-01
Exercise
2021-09-02
4:29 pm
N/A
N/A
REPLIGEN CORPRGENDAWES KAREN A
Director
3,459$38.7693,921
(Direct)
View
2021-07-13
Exercise(A)
2021-07-22
6:53 pm
N/A
2025-07-21
REPLIGEN CORPRGENDAWES KAREN A
Director
2,929$0117,462
(Direct)
View
2021-07-13
Exercise(A)
2021-07-22
6:53 pm
N/A
N/A
REPLIGEN CORPRGENDAWES KAREN A
Director
2,929$41.19117,462
(Direct)
View
2021-07-13
Exercise
2021-07-15
5:17 pm
N/A
2025-07-21
REPLIGEN CORPRGENDAWES KAREN A
Director
2,929$0117,462
(Direct)
View
2021-07-13
Exercise
2021-07-15
5:17 pm
N/A
N/A
REPLIGEN CORPRGENDAWES KAREN A
Director
2,929$41.19117,462
(Direct)
View
2021-05-13
Option Award
2021-05-17
9:50 pm
2022-05-13
2031-05-13
REPLIGEN CORPRGENDAWES KAREN A
Director
2,126$0117,575
(Direct)
View
2021-05-11
Exercise
2021-05-13
5:01 pm
N/A
2021-12-15
REPLIGEN CORPRGENDAWES KAREN A
Director
15,000$0115,449
(Direct)
View
2021-05-11
Exercise
2021-05-13
5:01 pm
N/A
N/A
REPLIGEN CORPRGENDAWES KAREN A
Director
15,000$3.22115,449
(Direct)
View
2021-04-29
Option Award
2021-05-04
8:25 pm
N/A
2031-04-29
Vaccitech plcVACCDAWES KAREN A
Director
34,328$034,328
(Direct)
View
2020-05-13
Option Award(A)
2020-05-21
9:06 pm
2021-05-13
2030-05-13
REPLIGEN CORPRGENDAWES KAREN A
Director
2,483$0121,717
(Direct)
View
2020-04-20
Exercise(A)
2020-05-21
9:03 pm
N/A
2020-09-16
REPLIGEN CORPRGENDAWES KAREN A
Director
20,000$0132,634
(Direct)
View
2020-04-20
Exercise(A)
2020-05-21
9:03 pm
N/A
N/A
REPLIGEN CORPRGENDAWES KAREN A
Director
20,000$3.3132,634
(Direct)
View
2020-05-13
Option Award
2020-05-19
8:46 pm
2021-05-13
2030-05-13
REPLIGEN CORPRGENDAWES KAREN A
Director
2,483$0121,717
(Direct)
View
2020-04-20
Exercise
2020-04-22
6:07 pm
N/A
2020-09-16
REPLIGEN CORPRGENDAWES KAREN A
Director
20,000$0132,634
(Direct)
View
2020-04-20
Exercise
2020-04-22
6:07 pm
N/A
N/A
REPLIGEN CORPRGENDAWES KAREN A
Director
20,000$3.3132,634
(Direct)
View
2019-06-17
Exercise
2019-06-19
7:00 pm
N/A
2019-09-11
REPLIGEN CORPRGENDAWES KAREN A
Director
20,000$0117,034
(Direct)
View
2019-06-17
Exercise
2019-06-19
7:00 pm
N/A
N/A
REPLIGEN CORPRGENDAWES KAREN A
Director
20,000$4.96117,034
(Direct)
View
2019-05-15
Option Award
2019-05-17
4:11 pm
2020-05-15
2029-05-15
REPLIGEN CORPRGENDAWES KAREN A
Director
4,245$0101,282
(Direct)
View
2019-05-08
Exercise
2019-05-09
11:28 am
2019-05-08
2019-05-08
Assertio Therapeutics IncASRTDAWES KAREN A
Director
31,250$0112,923
(Direct)
View
2019-05-07
Option Award
2019-05-09
11:28 am
N/A
N/A
Assertio Therapeutics IncASRTDAWES KAREN A
Director
39,584$0112,923
(Direct)
View
(A) Indicate amendment filing.